PepScribe

Cost & access

Does insurance cover HRT? - Reddit

Last updated July 1, 2026

More: Clinical standards · Pharmacy partners

Whether insurance covers HRT depends on three things: your specific plan, the hormone formulation prescribed, and whether your provider bills it under a covered diagnosis. This article walks through what most plans actually cover, where the gaps are, and what the cash-pay path looks like.

Quick answer

Most commercial insurance plans cover FDA-approvedhormone therapy formulations — estradiol patches, oral progesterone (Prometrium), and testosterone injections for diagnosed male hypogonadism — when medically indicated and prescribed by a licensed clinician, but they generally do not cover compounded HRT from 503A pharmacies because compounded medications lack the NDC numbers that map to insurance formularies.

Cash-pay telehealth HRT typically runs $100–$300 per month when annualized across consultation, labs, and medication — often less than high-deductible insurance cost-sharing.

Key takeaways

  • FDA-approvedestradiol patches, oral progesterone, and testosterone for diagnosed male hypogonadism are widely covered on commercial formularies — usually at Tier 1–2.
  • Custom-compounded bioidentical HRT from 503A pharmacies has no NDC number, so it is generally not covered and runs about $60–$200/month out of pocket.
  • Testosterone for women is FDA-approved only as a single patch for surgically induced menopause; off-label compounded testosterone for women is not covered.
  • Prior authorization is the most common hurdle — especially for testosterone and brand-name estrogens — and denials can be appealed with documented medical necessity.
  • Cash-pay HRT through telehealth typically totals $100–$300/month across consult, labs, and medication, and FSA/HSA funds can cover compounded prescriptions.

Deciding between the insurance route and cash-pay HRT? A licensed clinician can review your labs and lay out what each path costs you.

Start your assessment

Does insurance cover HRT — and which formulations qualify?

FDA-approvedhormone therapy formulations are generally on commercial insurance formularies, but tier placement and cost-sharing vary. Compounded hormone therapy — including most custom-dosed bioidentical regimens from 503A pharmacies — is typically not covered by insurance.

The practical implication: if your clinician prescribes an FDA-approved estradiol patch, oral progesterone, or testosterone (for men with diagnosed hypogonadism), there is a reasonable chance your insurance covers part of the cost. If your clinician prescribes a custom-compounded cream, gel, or pellet from a 503A pharmacy, expect to pay out of pocket.

What does FDA-approved HRT look like on formulary?

Several FDA-approved hormone therapy options are commonly on commercial insurance formularies:

  • Estradiol (estrogen): Available as patches (Vivelle-Dot, Climara, Minivelle), gels (Divigel, EstroGel), sprays (Evamist), and oral tablets. Generic estradiol patches and tablets are widely covered. Brand-name versions may be on higher formulary tiers.
  • Progesterone: Prometrium (micronized progesterone) is FDA-approved and typically covered as a Tier 2 generic. Synthetic progestins (medroxyprogesterone acetate, norethindrone) are also covered on most formularies.
  • Testosterone (men): Testosterone gels (AndroGel, Testim), patches (Androderm), injections (testosterone cypionate, enanthate), and pellets prescribed for diagnosed male hypogonadism are often covered, though prior authorization is common.
  • Testosterone (women): FDA approval in women is limited to one patch formulation for surgically induced menopause. Off-label compounded testosterone for women is generally not covered.

Coverage within each category varies by plan. The best way to confirm coverage is to call the member services number on your insurance card and ask specifically about the formulation and NDC code your clinician intends to prescribe.

HRT typeFDA-approved?Typical commercial coverageCash-pay range / mo
Estradiol patches / gel (generic)YesUsually Tier 1–2; widely covered$15–$60
Progesterone (Prometrium / generic)YesTypically covered (Tier 2)$20–$50
Testosterone (men, diagnosed hypogonadism)YesOften covered; PA common$30–$100
Testosterone (women, off-label)No (compounded)Generally not covered$60–$150
Custom-compounded bioidentical HRTNo (503A)Generally not covered$60–$200

The dividing line is the NDC number: FDA-approved hormones carry one and map to a formulary, while custom-compounded HRT doesn’t — which is why it almost always lands in the cash-pay column.

Why is compounded HRT generally not covered by insurance?

Insurance plans operate through formularies — lists of approved medications with assigned cost-sharing tiers. FDA-approved drugs have NDC (National Drug Code) numbers that map to formulary entries. Compounded medications prepared by 503A pharmacies are individualized preparations made for a specific patient; they do not have NDC numbers and are not on standard formularies.

Some patients have successfully submitted compounded HRT claims as out-of-network pharmacy claims or sought reimbursement through FSA/HSA accounts (which do cover compounded prescription medications). But insurance reimbursement for compounded hormones is the exception, not the rule.

Why is prior authorization the most common coverage hurdle?

Even when HRT formulations are on formulary, prior authorization (PA) is a common requirement — particularly for testosterone therapy and higher-cost estrogen formulations. PA requires your clinician to submit documentation justifying the prescription before the plan will cover it.

For testosterone therapy in men, insurance plans typically require a confirmed lab value showing low testosterone plus symptoms. For women, PA requirements for off-label testosterone vary widely. For menopause hormone therapy, PA is less common for standard formulations but may appear for brand-name products or higher doses.

Your telehealth clinician should be able to assist with PA documentation. If a PA is denied, you have the right to appeal. Your clinician’s documentation of medical necessity is the foundation of a successful appeal.

What does the cash-pay path actually cost?

For patients who are uninsured, underinsured, or choosing compounded HRT, cash-pay telehealth has made hormone therapy significantly more accessible over the past several years. What to expect on the cash-pay path:

  • Consultation fee: Telehealth providers typically charge a one-time or periodic consultation fee for clinician review. This is separate from the medication cost.
  • Lab work: Hormone therapy requires baseline labs (testosterone, estradiol, complete blood count, metabolic panel at minimum). Lab costs vary but can often be ordered through lower-cost direct-pay lab services.
  • Medication:FDA-approved generic formulations (estradiol patches, progesterone capsules, testosterone cypionate) are often available at low cost through GoodRx or similar discount programs at retail pharmacies. Compounded formulations from 503A pharmacies typically run $60–$200 per month depending on what is prescribed.

Total cash-pay cost for ongoing HRT through a telehealth platform typically runs $100–$300 per month when annualized across consultation, labs, and medication. For many patients, this compares favorably to high-deductible insurance plans with significant cost-sharing.

Why are labs required for HRT?

Responsible hormone therapy requires labs — before starting and at follow-up intervals. This is not optional clinical ceremony. Lab values confirm whether your hormone levels support the therapy, identify contraindications (elevated hematocrit, abnormal liver function, PSA in men), and allow dose adjustments based on actual response.

Providers offering HRT without any lab requirement are cutting corners that protect patients. Clinician-supervised therapy with labs is the standard. PepScribe’s HRT programs require baseline labs and include follow-up monitoring as part of the care model.

Frequently asked questions

Does insurance cover HRT for menopause?

Many insurance plans cover FDA-approved hormone therapy formulations for menopause symptoms when medically indicated and prescribed by a licensed clinician. Coverage depends on your specific plan, formulary tier, and whether the formulation is FDA-approved or compounded. Compounded hormones are generally not covered by insurance.

Does Medicare cover HRT?

Medicare Part D covers some FDA-approved hormone therapy medications. Coverage varies by plan and formulary. Compounded bioidentical hormones are typically not covered under Medicare. If you are on Medicare, confirm with your Part D plan what HRT formulations are on your formulary.

Does insurance cover testosterone therapy for women?

Testosterone therapy for women is FDA-approved only in a patch formulation for surgically induced menopause. Many physicians prescribe compounded testosterone gels or creams for women off-label. Insurance generally does not cover off-label compounded testosterone for women, making cash-pay the typical route.

Does insurance cover bioidentical HRT?

FDA-approved bioidentical hormone formulations (estradiol patches, gels, and progesterone capsules like Prometrium) are typically covered on formulary. Custom-compounded bioidentical HRT from 503A pharmacies is generally not covered by insurance. Coverage for the FDA-approved bioidentical options varies by plan and tier.

How much does HRT cost without insurance?

FDA-approved HRT formulations range from roughly $30–$200 per month at retail without insurance, depending on type and dose. Custom-compounded hormone therapy from 503A pharmacies typically runs $60–$200 per month depending on formulation. Clinician fees add to the total cost but are often separated from the medication cost on telehealth platforms.

Can I get HRT through a telehealth provider without insurance?

Yes. Licensed telehealth providers can evaluate you, prescribe FDA-approved or compounded HRT based on your labs and history, and send the prescription to a licensed pharmacy for delivery. No in-person office visit is required in most states.

References

  1. Hormone therapy for postmenopausal women. New England Journal of Medicine (Pinkerton JV) — PMID 32023371 (2020).
  2. Testosterone therapy in women: an updated systematic review and meta-analysis. Lancet Diabetes & Endocrinology (Islam et al.) — PMID 31353194 (2019).
  3. Menopause Practice: A Clinician's Guide (NAMS). The Menopause Society (formerly NAMS) — Clinical Resource (2022).

Get your hormone levels assessed.

Clinician review within 24 hours. Labs ordered. FDA-approved and compounded options available based on your results.